With scores of scientists exploring dozens of ideas on how to detect or even cure ovarian cancer, the Rivkin Center is on the cutting edge of ovarian cancer research. We keep a finger on the pulse of research from the world over, and we’ll share it with you here, along with news and insights from our staff, Scientific Board, other experts in the field, and patients and family members affected by ovarian cancer.

Announcing the 2018 Rivkin Center Research Grant Awardees

infographic-header

As one of the largest private funders of ovarian cancer research, we’re excited to announce the awardees of this year’s pilot and scholar research grants. Over 170 applications poured in from around the world. Fourteen were chosen. Why is funding scientific research important? Ovarian cancer kills more than 22,000 women every year in the United […]

Creating a Philanthropic Legacy

legacy-planning

When Susun Livingston learned she had an advanced stage of ovarian cancer in 2001, her life changed forever. During her clinical trial treatment, Susun heard about the SummeRun & Walk  for ovarian cancer and decided to walk the course no matter how long it took her. Amazed at the attendance, organization and excitement around the […]

Meet a CanCan Facilitator: Gail Fay

gail-fay

The Rivkin Center’s CanCan Program The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops. CanCan facilitators help educate women about their health, and about their breast and ovarian cancer risks. Say hello to Gail Fay, CanCan instructor.   About Gail Where are you from? Burbank, California Where do you live now […]

Announcing the 25th Annual Swedish SummeRun and Walk for Ovarian Cancer

Registration for the Swedish SummeRun and Walk for Ovarian Cancer is now open! The SummeRun & Walk for Ovarian Cancer was founded in 1994 by renowned Swedish Cancer Institute medical oncologist Saul E. Rivkin, MD, in partnership with Swedish Medical Center. Dr. Rivkin and his five daughters were mourning the loss of Dr. Rivkin’s late wife, and […]

Meet a CanCan Ambassador: Sarah Czaja

sarah-czaja

Meet an Ambassador The Rivkin Center for Ovarian Cancer’s CanCan program provides free health education workshops across the west coast. CanCan campus ambassadors are the feet-on-the-ground representatives at colleges for the Rivkin Center, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Sarah Czaja, CanCan ambassador at […]

The Rikvin Center to Host 1st NW Gynecological Cancer Symposium

Free event to foster collaboration between scientists SEATTLE – Dec 1, 2017 – The Rivkin Center for Ovarian Cancer is proud to present the 1st biennial Northwest Gynecological Cancer Symposium (NGCS) to be held on Monday, December 4th, 2017 from 8am – 7pm at Pelton Auditorium at Fred Hutch in Seattle. NGCS is designed to […]

Highlights of Ovarian Cancer Science from ASCO

Dr. Rivkin and I attended the annual meeting of the American Society of Clinical Oncology (ASCO)—a gathering of 38,000 oncology experts from all over the world—in early June in Chicago, Illinois. In addition to oncologists, the attendees included researchers, educators, advocates, research funders, survivors and representatives from genetic testing, drug and other services companies. Our […]

New study extends benefit of Rucaparib PARP inhibitor to women with BRCA defects in tumors who do not carry inherited BRCA mutations

A study published in Lancet Oncology by Dr. Iain McNeish (2016 Rivkin Pilot Award Recipient), Dr. Elizabeth Swisher (2009 Rivkin Pilot Award Recipient), and colleagues provided key data that helped fuel the FDA’s recent approval of rucaparib for ovarian cancers with defects in the BRCA1 and BRCA2 genes in women previously treated with two or more chemotherapies.

X